ESSEX INVESTMENT MANAGEMENT CO LLC

Position in LGND — Ligand Pharmaceuticals Inc

CIK 201772 BOSTON, MA

Position in LGND

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$13,771,093

+$2,099,554 QoQ

Shares Held

43,567

-25.5% QoQ

Ownership

0.219%

of shares outstanding

% of Portfolio

1.85%

of 13F equity value

Holder Rank

#75

of 411 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 72% Shared 0% None 28%

Healthcare · as of Jun 30, 2026

ESSEX INVESTMENT MANAGEMENT CO LLC holds $67,663,995 across 13 Biotechnology names. LGND ranks #1 (20.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LGND	Ligand Pharmaceuticals Inc This page	43,567	$13,771,093
2	MIRM	Mirum Pharmaceuticals, Inc.	105,669	$12,370,669
3	TVTX	Travere Therapeutics, Inc.	133,866	$7,604,927
4	JAZZ	Jazz Pharmaceuticals plc	21,665	$5,220,615
5	OCUL	Ocular Therapeutix, Inc	482,154	$4,734,752
6	INSM	INSMED Inc	42,991	$4,583,700
7	PGEN	Precigen, Inc.	706,294	$4,025,875
8	AXSM	Axsome Therapeutics, Inc.	16,244	$3,976,043

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$13,771,093	43,567	-25.5%	Shares	Sole	2026-08-06
2026-03-31	$11,671,539	58,460	-2.6%	Shares	Sole	2026-05-11
2025-12-31	$11,347,981	60,020	-1.8%	Shares	Sole	2026-02-13
2025-09-30	$10,830,693	61,142	+0.5%	Shares	Sole	2025-11-06
2025-06-30	$6,912,880	60,810	-1.4%	Shares	Sole	2025-08-12
2025-03-31	$6,487,348	61,702	-5.4%	Shares	Sole	2025-05-07
2024-12-31	$6,991,216	65,247	-5.6%	Shares	Sole	2025-02-07
2024-09-30	$6,921,023	69,148	-2.3%	Shares	Sole	2024-10-10
2024-06-30	$5,963,922	70,780	—	Shares	Sole	2024-08-12
No filing history on record for this holder in this stock.